‘Is it safe for me to have a vaccine for Covid – what do we know so far?’ ‘Are there any effective treatments for Covid?’ ‘What are my risks as a kidney patient’ ‘What should I be doing to keep myself safe?’ ‘How can I understand more about my individual risk?’
Following on from the success of our webinars on Covid-19 and dialysis and transplant, Kidney Care UK, the Renal Association and the British Renal Society would like to invite you to join this free Zoom webinar for patients, carers and healthcare professionals on the topic of Covid-19 and chronic kidney disease. Please book here. Throughout the pandemic we’ve been hearing from patients and their families regarding concerns about shielding, vaccine development, recovering from the virus, and many more vitally important topics. Now a panel of renal medical professionals including Dr Andrew Frankel, Professor Richard Haynes and Dr Rebecca Suckling, will be online to answer your questions about coronavirus and chronic kidney disease, including vaccines and treatment outcomes for kidney patients with Covid-19.
Dr Rebecca Suckling is a consultant nephrologist, looking after patients with kidney diseases both on the ward at St Helier Hospital and in clinics at St Helier Hospital and other locations in Surrey. She is also Associate Medical Director for Epsom and St Helier NHS Trust. Dr Suckling has specialist interests in hypertension, running a shared hypertension clinic, and in predialysis, helping prepare patients for dialysis and possible kidney transplantation. She has additional research interests in hypertension. Dr Suckling is the chair of the patient information committee which is a joint committee with Kidney Care UK and the Renal Association and provides high quality information on kidney diseases and the consequences of them which is jointly developed with patients.
Dr Andrew Frankel has been working as a consultant nephrologist at Imperial College Healthcare NHS trust since 1995. He has experience in managing all aspects of kidney disease but has a particular interest in relation to the management of diabetes in the context of kidney disease. He was the director of Imperial’s Foundation School from its inception to 2010, London lead for Foundation Training and Postgraduate Dean for south London from 2013 and 2018.
Professor Richard Haynes did his pre-clinical medical studies in Cambridge before moving to Oxford for his clinical studies and qualified in 2000. He completed his training in renal medicine in 2011 and was appointed as an honorary consultant at the Oxford Kidney Unit. He is now Programme Leader in the MRC Population Health Research Unit for the programme in Randomised Trials in Cardiovascular and Metabolic Disease. Richard is part of the RECOVERY Collaborative Group which leads a large scale clinical trial of potential treatments for people hospitalised with Covid-19. Over 17,000 people have enrolled in the trial to date.
Fiona Loud will be chairing the discussion. She has been policy director of Kidney Care UK since 2013 and was previously Director of the Kidney Alliance. Fiona is involved with numerous other groups, working to improve standards of care for kidney patients. She has been leading the charities policy and campaigning response to the Covid-19 pandemic. Fiona spent 5 years on dialysis after her kidneys failed, before receiving a transplant from her husband in late 2006.
The Webinar will last for approximately one hour. It will be recorded and the video, along with a summary report, will be shared afterwards on our website. Click here to book your place and please submit questions in advance by sending them to [email protected] by Thursday 26 November and put 'Webinar questions' as the subject.
Please note that we will not be able to cover individual treatment issues, but will be able to cover broader topics through the session. We’re really looking forward to hearing from you.
